GCK-01

N/A

Report date: 2026/02/28 20:00:37

Base Information

Drug NameGCK-01
Drug Alias NameGCK-01GCK01
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionB-lymphocyte antigen CD20 inhibitors
TargetsB-lymphocyte antigen CD20
Therapy Area/IndicationsLymphoma, Follicular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsLymphoma, Follicular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A